Consistent with the lipid component of our Cav-1-sphingolipid signature, investigations of advanced cases of castration-resistant prostate cancer identified a distinct plasma lipid signature that includes sphingolipids and glycosphingolipids and that associates with poor prognosis63, further supporting the findings we report here. This evidence concerns the gene CAV1 and prostate cancer.